Evidence map›Paper›PMID 38568825›Full record

ReviewJournal of veterinary science2024

Butyric acid and prospects for creation of new medicines based on its derivatives: a literature review.

Lyudmila K Gerunova, Taras V Gerunov, Lydia G P'yanova, Alexander V Lavrenov, Anna V Sedanova, Maria S Delyagina, Yuri N Fedorov, Natalia V Kornienko, Yana O Kryuchek, Anna A Tarasenko

Open access · goldAbstract readReview
In one paragraph

Review in Journal of veterinary science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Animals : an open access journal from MDPI · 2025
    Article
  6. Article
  7. Article
  8. Foods (Basel, Switzerland) · 2025
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Role of SimulatedNutrients · 2024
    Article
  15. The Impact ofMicroorganisms · 2024
    Review
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Lyudmila K GerunovaDepartment of Pharmacology and Toxicology, Omsk State Agrarian University named after P. A. Stolypin, Omsk 644008, Russian Federation.ORCID https://orcid.org/0000-0003-0835-9352
Taras V GerunovDepartment of Pharmacology and Toxicology, Omsk State Agrarian University named after P. A. Stolypin, Omsk 644008, Russian Federation.ORCID https://orcid.org/0000-0002-5594-2666
Lydia G P'yanovaDepartment of Materials Science and Physicochemical Research Methods, Center of New Chemical Technologies BIC, Omsk 644040, Russian Federation.ORCID https://orcid.org/0000-0002-6207-0878
Alexander V LavrenovDepartment of Materials Science and Physicochemical Research Methods, Center of New Chemical Technologies BIC, Omsk 644040, Russian Federation.ORCID https://orcid.org/0000-0002-9246-7964
Anna V SedanovaDepartment of Materials Science and Physicochemical Research Methods, Center of New Chemical Technologies BIC, Omsk 644040, Russian Federation.ORCID https://orcid.org/0000-0002-1832-253X
Maria S DelyaginaDepartment of Materials Science and Physicochemical Research Methods, Center of New Chemical Technologies BIC, Omsk 644040, Russian Federation. medugli@mail.ru.ORCID https://orcid.org/0000-0002-6533-0321
Yuri N FedorovLaboratory of Immunology, All-Russian Research and Technological Institute of Biological Industry, pos. Biokombinata, Shchelkovskii Region, Moscow Province 141142, Russian Federation.ORCID https://orcid.org/0000-0001-7268-3734
Natalia V KornienkoDepartment of Materials Science and Physicochemical Research Methods, Center of New Chemical Technologies BIC, Omsk 644040, Russian Federation.ORCID https://orcid.org/0000-0003-3962-7049
Yana O KryuchekDepartment of Pharmacology and Toxicology, Omsk State Agrarian University named after P. A. Stolypin, Omsk 644008, Russian Federation.ORCID https://orcid.org/0000-0003-0808-9911
Anna A TarasenkoDepartment of Pharmacology and Toxicology, Omsk State Agrarian University named after P. A. Stolypin, Omsk 644008, Russian Federation.ORCID https://orcid.org/0000-0001-7314-9998
Center for Theoretical Problems of Physicochemical Pharmacology · RUOmsk State Agrarian University · RUResearch and Technological Institute of Biological Industry · RU

Funding

Boreskov Institute of Catalysis FWUR-2024-0039
6 · The paper itself

Abstract

The widespread use of antimicrobials causes antibiotic resistance in bacteria. The use of butyric acid and its derivatives is an alternative tactic. This review summarizes the literature on the role of butyric acid in the body and provides further prospects for the clinical use of its derivatives and delivery methods to the animal body. Thus far, there is evidence confirming the vital role of butyric acid in the body and the effectiveness of its derivatives when used as animal medicines and growth stimulants. Butyric acid salts stimulate immunomodulatory activity by reducing microbial colonization of the intestine and suppressing inflammation. Extraintestinal effects occur against the background of hemoglobinopathy, hypercholesterolemia, insulin resistance, and cerebral ischemia. Butyric acid derivatives inhibit histone deacetylase. Aberrant histone deacetylase activity is associated with the development of certain types of cancer in humans. Feed additives containing butyric acid salts or tributyrin are used widely in animal husbandry. They improve the functional status of the intestine and accelerate animal growth and development. On the other hand, high concentrations of butyric acid stimulate the apoptosis of epithelial cells and disrupt the intestinal barrier function. This review highlights the biological activity and the mechanism of action of butyric acid, its salts, and esters, revealing their role in the treatment of various animal and human diseases. This paper also discussed the possibility of using butyric acid and its derivatives as surface modifiers of enterosorbents to obtain new drugs with bifunctional action.

Indexed as

Anti-Infective AgentsSaltsAnimalsButyric AcidEpithelial CellsHistone DeacetylasesHumansAnti-Infective AgentsButyric AcidHistone DeacetylasesSaltsanimal husbandrybutyratesButyric acidsodium butyrate

Identifiers

PMID38568825
PMCPMC10990906
OpenAlexW4392733019

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.